Reference page — cumulative record through Monday, October 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
EspoCRM
Product reference — EspoCRM by Espocrm · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 23 | 23 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 5.5 | .0023 | 1 | 3 | 17 | 2 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▂▁▁▁▂█
| Month | New CVEs |
|---|---|
| 2026-05 | 2 |
| 2026-06 | 0 |
| 2026-07 | 0 |
| 2026-08 | 0 |
| 2026-09 | 3 |
| 2026-10 | 18 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-92298 | 6.3 | 35.8 | MEDIUM | — | 2026-09-16 |
| CVE-2026-47168 | 9.1 | 35.1 | CRITICAL | — | 2026-10-15 |
| CVE-2026-88896 | 6.9 | 29.5 | MEDIUM | — | 2026-09-10 |
| CVE-2026-41141 | 6.5 | 28.4 | MEDIUM | — | 2026-05-28 |
| CVE-2026-59994 | 4.3 | 26.5 | MEDIUM | — | 2026-10-15 |
| CVE-2026-63130 | 5.5 | 25.3 | MEDIUM | — | 2026-10-15 |
| CVE-2026-90934 | 8.7 | 21.7 | HIGH | — | 2026-09-14 |
| CVE-2026-41160 | 4.3 | 21.8 | MEDIUM | — | 2026-05-28 |
| CVE-2026-75505 | 6.0 | 20.5 | MEDIUM | — | 2026-10-15 |
| CVE-2026-105831 | 5.3 | 17.6 | MEDIUM | — | 2026-10-08 |
| CVE-2026-105832 | 5.3 | 17.3 | MEDIUM | — | 2026-10-08 |
| CVE-2026-46691 | 6.5 | 12.9 | MEDIUM | — | 2026-10-15 |
| CVE-2026-46694 | 6.5 | 12.9 | MEDIUM | — | 2026-10-15 |
| CVE-2026-77460 | 6.5 | 12.9 | MEDIUM | — | 2026-10-15 |
| CVE-2026-53575 | 2.7 | 12.3 | LOW | — | 2026-10-15 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-75505 | 6.0 | 20.5 | MEDIUM | — | 2026-10-15 |
| CVE-2026-55154 | 5.4 | 10.5 | MEDIUM | — | 2026-10-15 |
| CVE-2026-46694 | 6.5 | 12.9 | MEDIUM | — | 2026-10-15 |
| CVE-2026-47168 | 9.1 | 35.1 | CRITICAL | — | 2026-10-15 |
| CVE-2026-59994 | 4.3 | 26.5 | MEDIUM | — | 2026-10-15 |
| CVE-2026-77460 | 6.5 | 12.9 | MEDIUM | — | 2026-10-15 |
| CVE-2026-53575 | 2.7 | 12.3 | LOW | — | 2026-10-15 |
| CVE-2026-46691 | 6.5 | 12.9 | MEDIUM | — | 2026-10-15 |
| CVE-2026-53574 | 7.6 | 10.5 | HIGH | — | 2026-10-15 |
| CVE-2026-55184 | 3.5 | 9.4 | LOW | — | 2026-10-15 |
| CVE-2026-63130 | 5.5 | 25.3 | MEDIUM | — | 2026-10-15 |
| CVE-2026-46708 | 4.3 | 8.0 | MEDIUM | — | 2026-10-15 |
| CVE-2026-109957 | 5.3 | 9.7 | MEDIUM | — | 2026-10-13 |
| CVE-2026-109958 | 5.3 | 12.0 | MEDIUM | — | 2026-10-13 |
| CVE-2026-109959 | 5.3 | 12.0 | MEDIUM | — | 2026-10-13 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Espocrm — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
